Revenio Group Oyj REG1V.HE
Nasdaq Helsinki · Healthcare · Medical Devices
10.48 EUR
−1.3%
2026-11-06
Keep this stock on your watchlist and set email alerts for prices, reports and important announcements where available.
Annual accounts for Revenio Group
| EUR million | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Income statement | ||||
| Revenue | 97 | 97 | 104 | 110 |
| EBITDA | 33 | 30 | 30 | 28 |
| Net income | 22 | 19 | 18 | 17 |
| Balance sheet | ||||
| Equity | 91 | 100 | 108 | 115 |
| Total debt | 20 | 18 | 13 | 11 |
| Cash | 32 | 22 | 21 | 26 |
| Net debt | −12 | −4 | −8 | −15 |
| Ratios and per share | ||||
| EBITDA margin | 33.8% | 31.1% | 29.5% | 25.3% |
| Profit margin | 22.4% | 19.8% | 17.9% | 15.9% |
| Return on equity | 23.9% | 19.1% | 17.2% | 15.2% |
| Earnings/share (EUR) | 0.69 | 0.60 | 0.58 | 0.55 |
| Book value/share (EUR) | 2.86 | 3.15 | 3.39 | 3.61 |
| Shares outstanding (M) | 32 | 32 | 32 | 32 |
From the annual statements (Yahoo Finance), in the currency the company reports in. Per-share figures use the shares at the year end. Charts and annual figures →
Key figures
| P/E | 19.1 |
| P/B | 2.9 |
| EV / EBITDA | 11.5 |
| Net debt / EBITDA | −0.6 |
| Return on equity | 15.2% |
| Profit margin | 15.9% |
| Beta 1Y | 0.39 |
| Revenue growth 1Y | +6.0% |
| Revenue CAGR 3Y | +4.2% |
| Earnings/share CAGR 3Y | −7.2% |
| ROE avg. 3Y | 17.2% |
Ratios use the latest annual report that was public 90 days after the year end.
Dividends per share (EUR)
| 2025 | 0.34 |
| 2024 | 0.32 |
| 2023 | 0.30 |
| 2022 | 0.28 |
Not investment advice. Figures may contain errors from the data source.